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Perhaps the most important advance
in respiratory physiology during the
past decade is the discovery of the
role of surface phenomena. This has
been in large measure the result of
pioneer work by Pattie, in England,
and Clements, in the United States.
The following is a simplified and
brief review of present knowledge of
surface tension, as it relates to normal
and abnormal pulmonary function.
(For further reading on the subject
pelase refer to these recent reviews:
Clements, 1962a and 1962b, Pattie,
1958, 1961 , and 1965, and Mead,
1960.)
First, what is surface tension? When
a liquid is in contact with the air, the
molecules at the surface of the liquid
will be under tension (fig. 1). This is
because, while the molecules away
from the surface are attracted equally
by other molecules from all directions,
those at the surface are influenced only
by molecules below and to the side, but
none above. The net effect is that the
surface molecules tend to be pulled
down, and therefore, the surface tends
to get smaller.
And because surface tension is a
force acting in the same plane as the
surface, e.g., like the pull on the cord
of a window curtain, it has units of
force per length, e.g., gm per cm or
dynes per cm, whereas pressure has the
units of force per area, e.g., gm per
cm2 or pounds per square inch.
Now, what could this have to do
with what goes on in the lungs? We
will begin to appreciate the link when
we consider the case of a gas-liquid
interface that has a spherical shape,
like that of an alveolus. A soap bubble
is a good example. Here, the tendency
of surface tension to shrink the surface
will ultimately result in collapse of the
bubble. And it can be shown that the
total forces tending to empty the bubble
will amount to twice the tension in the
wall divided by the radius of curvature.
This relationship is known as the law
of Laplace, and it appears to hold for
alveoli just as well as it holds for soap
bubbles. It means simply that for a
sphere, the surface forces will increase
if the tension in the wall increases or
if the radius of curvature decreases. It

* Presented at the 1964 Stoneburner
Symposium.
t Recipient of U. S. Public Health
Service Career Development A ward HEK3-18,432 from the National Heart Institute.
52

0

GAS

SURFACE

-..,.

-

----~ - - - - ....:F.'l~-=
- -f~E~----~~--rs_-

~~_e==_4~~~~~~-~-;-;

f{fl!i{{{iil~~
---- -- - --- - ------

Fig. I-Molecules at a gas-liquid interfa ce are under tension (after Mead, 1960).

Fig. 2-A system of bubbles in parallel is unstable; smaller bubbles have
greater surface forces (P) and therefore
tend to collapse first (after Mead, 1960).

Fig. 3-Pulmonary alveoli are inherently
unstable, but a surface-active lining (surfactant) lowers alveolar surface tension
and thus protects them against atelectasis.
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Fig. 4-Schema of fluid exchange in
lung.

also means that, for the surface forces
to remain balanced, a decrease in radius of curvature must be counteracted
by a decrease in tension. A beautifully
clear presentation of these relations was
given by Mead (1960).
To get a step closer to the lung, we
now examine what happens when two
soap bubbles are blown at the end of
a Y-tube and are arranged, so to
speak, in parallel-like two alveoli
with a common airway (fig. 2). If one
bubble happens to be smaller than the
other, we might expect that air would
leave the larger bubble to enter the
smaller bubble, until the two became
equal in size. But this is not what happens. According to the law of Laplace,
the smaller bubble must have a higher
surface force (P), since its radius of
curvature is smaller. In other words,
the forces tending to collapse the
smaller bubble are greater than those
trying to empty the larger bubble. As
a result, the smaller bubble empties itself into the larger one.
Turning now to the lung, we find
that we have hundreds of millions of
alveoli, offering a large area of contact
between blood and gas (of the order of
70 M 2 ) , sufficient to permit the exchange of oxygen and carbon dioxide.
At the same time, we find that the
alveoli also present, on their inner surface, a large area of contact between
air and tissue fluid. This means that
the forces of surface tension are bound
to come into play. And since the alveoli are not all equal in size, and since
all of them get smaller during expiration, then, just as the smaller soap
bubble emptied into the larger one, the
smaller alveoli would tend to collapse
into the larger ones, until we were left
with a single large air space. That, of
course, would be disastrous, for the
processes of gas exchange would no
longer be possible.
Fortunately, however, this does not
happen, because the lung is endowed
with a special detergent, or surfaceactive material, which is capable of
reducing surface tension and adjusting
it when necessary. This is surfactant
(fig. 3). Pulmonary surfactant, therefore, stabilizes the alveoli and protects them against an inherent tendency
for collapse or atelectasis. It does so
by decreasing surface tension in
smaller alveoli, thereby balancing out
the effect of their smallness and, con-

sequently, maintaining uniform surface
forces throughout the lung and
throughout the respiratory cycle.
Another important function of pulmonary surfactant is explained in figure 4. Normally, a delicate balance of
fluid exchange exists between alveoli
on the one hand, and capillaries on
the other; only a thin fluid film lines
the alveoli. The forces of hydrostatic
pressure, alveolar fluid osmotic pressure, and surface tension, all tend to
drive fluid out of the capillaries and
into the alveoli. In the absence of surfactant, these forces would be opposed
only by the plasma colloid osmotic
pressure, and fluid and blood tend to
leak into the alveolar spaces. Pulmonary surfactant, therefore, protects the
alveoli not only against atelectasis, but
also against pulmonary edema and
hemorrhage.
Consequently, we would expect lack
of surfactant to result in three major
pathologic changes in the lung; atelectasis, edema and hemorrhage-perhaps
in varying degrees of predominance.
This is indeed what happens when the
surfactant is missing or ineffective
(fig. 5).
At present, the available methods
for evaluating lung surface tension
properties are indirect and not quantitative. A sample of lung tissue (1 to 3
gm) is minced and extracted in saline.
The extract is then filtered and poured
onto the trough of a surface balance
(Wilhelmy type) that permits automatic compression and re-expansion of
the surface area and the simultaneous
recording of surface tension (fig. 6) .
The latter measurement depends on the
pull exerted on a thin platinum strip
by the superficial layer of the fluid,
which should contain any surface-active substances that may be present in
the lung. The ability to reach low surface tensions (below 10 dynes per cm),
and a wide variation of tension with
changes in surface area, are characteristic of normal lung extracts. Lungs
with abnormal surface properties give
extracts that fail to reach a low surface
tension even on maximal compression.
How is pulmonary surfactant normally formed? What is its chemical
nature? And why is it deficient in
some conditions of disease or experiment? The answers to these questions
are only partially known. There is evidence that certain granular alveolar
cells are responsible for manufacturing
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this special surface-active material lining the alveoli. With the electron microscope, it has been suggested that
mitochondrial activity in these cells,
manifested as transformation into
lamellar forms, is closely related to the
formation of surfactant.
As for its chemical composition,
pulmonary surfactant appears to be a
complex of lipids and protein, the chief

component responsible for surface activity being dipalmityl lecithin, a phospholipid. (Lecithin is commonly used
commercially for its emulsifying properties, e.g., in candy and cookies.) The
protein appears to be an a-globulin.
Adult mammalian lung can actively incorporate circulating fatty acids into
phospholipid and can also synthesize
its own fatty acids.

Alveolar surfactant has been found
missing or lacking in a number of
clinical and experimental situations
(table 1). The finding of abnormal surface activity of lung extracts from infants dying of hyaline membrane disease (respiratory distress syndrome)
was the first time surface tension was
linked to a disease entity. Thanks to
Avery and Mead (1959), this discovery

TABLE 1

Clinical and Experimental Conditions
That May Be Associated with Insufficient or Ineffective Surfactant

1. Immaturity
2. Hyaline membrane disease
3. Pulmonary artery occlusion
4. Pulmonary
edema

5. Cardiopulmonary bypass
6. Vagotomy (in
some species)
7. O, poisoning
8. Severe respiratory acidosis

TABLE 2

Present Knowledge of Pulmonary
Surfactant
1. A surface-active material (surfact-

Fig. 5-Lung of dog showing edema, hemorrhage, and microscopically, areas of atelectasis. Surface tension of saline extract of this lung was abnormall y high.

Fig. 6-Photograph of balance for measuring surface tension of lung extracts (manufactured by Kenneth Wilson, 508 W. Joppa Road, Towson, Md.
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ant) lines the pulmonary alveoli of
adult mammals.
2. It is probably a lipoprotein (phospholipid +globulin) .
3. It is probably synthesized in the
lung , by alveolar cells.
4. Impaired synthesis , excessive de pletion, or inhibition of surfactant
leads to alveolar instability : atelectasis , hemorrhage, and edema .

put the subject in a totally different
light; from one largely of theoretical
interest to a practical and tangible
problem. Abnormal extract activity is
also found in several conditions that
are associated with impairment of pulmonary blood flow: occlusion of a
pulmonary artery, following cardiopulmonary bypass through a pump oxygenator, and as a result of induced pulmonary edema. Pulmonary surface
tension properties are also probably
impaired following vagotomy in some
small animals, in the rather unusual
experimental preparation where an animal is made to breathe while immersed

under fluid-thus using its lungs as
gills, and in oxygen toxicity, due to
prolonged breathing of pure oxygen,
particularly under increased pressure.
T his latter condition has received considerable attention because of its importance to astronauts and other space
travelers and in therapy with hyperbaric oxygenation. The list of conditions in which surfactant may be altered
gets longer as more work is being done
on the subject.
The manner in which pulmonary
surface activity is altered in these conditions is not clear. In some cases there
is probably impaired synthesis of surfactant, in others, a circulating inhibitor, and in others yet there may be too
rapid dissipation. In any event, the importance of surface tension in pulmonary disease is now fully recognized,
and future work will no doubt provide
more answers.
To summarize (table 2), alveoli of
mammalian lungs are normally lined by
a surface-active material or surfactant,
composed chiefly of phospholipids and
protein. Surfactant is normally synthesized in the lung. Formation depends, among other things, on normal
pulmonary blood flow, intact vagus,
and the activity of certain alveolar cells
that have reached an adequate level of
maturity. Its absence leads to alveolar
instability: atelectasis, pulmonary hemorrhage, and edema.

"The diver is generally safe
enough on the bottom, but when
he comes up care is needed. His
danger is from bubbles which may
form in his blood or tissues when
the pressure is taken off, just as
they form in a bottle of lemonade
or soda water. There is a story
that when one of the first tubes
was being driven under the
Thames, the directors of the company celebrated its arrival under
the middle of the river by having
lunch in the tunnel. They went
into an air lock, the steel door
was shut behind them, and the
pressure raised till it reached that
in the end section of the tunnel.
Then a door at the other end was
opened, and they went on to lunch.
As we know, company directors
always have champagne for lunch,
and these were no exception to
the rule. But when the bottles were
opened the champagne did not
fizz. The pressure outside the bottles was as big as that inside them.
However, the directors drank the
wine. After lunch they went back
to the lock, and the pressure was
lowered. They soon began to feel
very uncomfortable. As the pressure fell the wine began to fizz, and
the financiers to suffer from inflation!"

J. B. S. Haldane, Adventures of a Biologist. New
York: Harper and Brothers
Publishers, 1940, pp. 80-81.
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